GLENMARK PHARMACEUTICALS LTD. - Glenmark Pharmaceuticals receives ANDA approval for Norgestimate and Ethinyl Estradiol Tablets USP, 0.18 mg/0.025 mg, 0.215 mg/0.025 mg, and 0.25 mg/0.025 mg
Download
|
< Back
|
24 Feb 2016
|
Glenmark Pharmaceuticals Ltd has informed BSE regarding a Press Release dated February 24, 2016, titled "Glenmark Pharmaceuticals receives ANDA approval for Norgestimate and Ethinyl Estradiol Tablets USP, 0.18 mg/0.025 mg, 0.215 mg/0.025 mg, and 0.25 mg/0.025 mg".
|
View all announcements for GLENMARK PHARMACEUTICALS LTD.
|
Source:
BSE India
|